Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alison M Kell

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Biorxiv : the Preprint Server for Biology|September 15, 2025
Specific and versatile monoclonal antibodies for hantavirus researchAutumn LaPointe, Kimberly Martinez, Christina Shou, et al.
Plos Pathogens|November 25, 2024
Seoul orthohantavirus evades innate immune activation by reservoir endothelial cellsStefan D Klimaj, Autumn LaPointe, Kimberly Martinez, et al.
Virus Research|February 8, 2012
Analysis of host genetic diversity and viral entry as sources of between-host variation in viral loadAndrew R Wargo, Alison M Kell, Robert J Scott, et al.
Biorxiv : the Preprint Server for Biology|July 27, 2021
Integrin activation is an essential component of SARS-CoV-2 infectionPeter Simons, Derek A Rinaldi, Virginie Bondu, et al.
Scientific Reports|October 15, 2021
Integrin activation is an essential component of SARS-CoV-2 infectionPeter Simons, Derek A Rinaldi, Virginie Bondu, et al.
Biorxiv : the Preprint Server for Biology|February 9, 2026
Discovering Novel Therapeutic V <sub>H</sub> Hs for Emerging Viruses: Perspectives from VEEV Selection StrategiesAutumn T LaPointe, Fortunato Ferrara, Jennifer M Zupancic, et al.
Frontiers in Immunology|April 16, 2026
Discovering novel therapeutic V<sub>H</sub>Hs for emerging viruses: perspectives from VEEV selection strategiesAutumn T LaPointe, Fortunato Ferrara, Jennifer M Zupancic, et al.
ACS Applied Materials & Interfaces|December 3, 2020
Highly Effective Inactivation of SARS-CoV-2 by Conjugated Polymers and OligomersFlorencia A Monge, Pradeepkumar Jagadesan, Virginie Bondu, et al.
Medrxiv : the Preprint Server for Health Sciences|October 14, 2020
Highly Effective Inactivation of SARS-CoV-2 by Conjugated Polymers and OligomersKirk S Schanze, David G Whitten, Alison M Kell, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2024
Viral susceptibility and innate immune competency of <i>Carollia perspicillata</i> bat cells produced for virological studiesVictoria Gonzalez, Cierra Word, Nahomi Guerra-Pilaquinga, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Biorxiv : the Preprint Server for Biology|September 15, 2025
Specific and versatile monoclonal antibodies for hantavirus researchAutumn LaPointe, Kimberly Martinez, Christina Shou, et al.
Plos Pathogens|November 25, 2024
Seoul orthohantavirus evades innate immune activation by reservoir endothelial cellsStefan D Klimaj, Autumn LaPointe, Kimberly Martinez, et al.
Virus Research|February 8, 2012
Analysis of host genetic diversity and viral entry as sources of between-host variation in viral loadAndrew R Wargo, Alison M Kell, Robert J Scott, et al.
Biorxiv : the Preprint Server for Biology|July 27, 2021
Integrin activation is an essential component of SARS-CoV-2 infectionPeter Simons, Derek A Rinaldi, Virginie Bondu, et al.
Scientific Reports|October 15, 2021
Integrin activation is an essential component of SARS-CoV-2 infectionPeter Simons, Derek A Rinaldi, Virginie Bondu, et al.
Biorxiv : the Preprint Server for Biology|February 9, 2026
Discovering Novel Therapeutic V <sub>H</sub> Hs for Emerging Viruses: Perspectives from VEEV Selection StrategiesAutumn T LaPointe, Fortunato Ferrara, Jennifer M Zupancic, et al.
Frontiers in Immunology|April 16, 2026
Discovering novel therapeutic V<sub>H</sub>Hs for emerging viruses: perspectives from VEEV selection strategiesAutumn T LaPointe, Fortunato Ferrara, Jennifer M Zupancic, et al.
ACS Applied Materials & Interfaces|December 3, 2020
Highly Effective Inactivation of SARS-CoV-2 by Conjugated Polymers and OligomersFlorencia A Monge, Pradeepkumar Jagadesan, Virginie Bondu, et al.
Medrxiv : the Preprint Server for Health Sciences|October 14, 2020
Highly Effective Inactivation of SARS-CoV-2 by Conjugated Polymers and OligomersKirk S Schanze, David G Whitten, Alison M Kell, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2024
Viral susceptibility and innate immune competency of <i>Carollia perspicillata</i> bat cells produced for virological studiesVictoria Gonzalez, Cierra Word, Nahomi Guerra-Pilaquinga, et al.
Pageof 3